Brain Tumor Diagnosis and Treatment

Brain Tumor Diagnosis and Treatment

Global Brain Tumor Diagnosis and Treatment Market to Reach $2 Billion by 2030
The global market for Brain Tumor Diagnosis and Treatment estimated at US$1.5 Billion in the year 2023, is expected to reach US$2 Billion by 2030, growing at a CAGR of 4.3% over the period 2023-2030. Primary Brain Tumor Diagnosis and Treatment, one of the segments analyzed in the report, is expected to record 4.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Secondary Brain Tumor Diagnosis and Treatment segment is estimated at 4.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $399.7 Million, While China is Forecast to Grow at 7.7% CAGR
The Brain Tumor Diagnosis and Treatment market in the U.S. is estimated at US$399.7 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$455.1 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 4.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -
  • AstraZeneca PLC
  • Carestream Health, Inc.
  • GE Healthcare
  • Hitachi Medical Corporation
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Brain Tumor Diagnosis and Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for PET-CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for PET-CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for PET-CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Other Diagnosis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 28: World Brain Tumor Diagnosis and Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 29: World Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Primary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Primary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Primary Brain Tumor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Secondary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Secondary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Secondary Brain Tumor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Lumbar Puncture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Lumbar Puncture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Lumbar Puncture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for EEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 42: World Historic Review for EEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: World 16-Year Perspective for EEG by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for Tissue Sampling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 45: World Historic Review for Tissue Sampling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: World 16-Year Perspective for Tissue Sampling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 47: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 48: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 50: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: USA Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: USA 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: USA Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: USA 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 56: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: USA Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: USA 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
CANADA
TABLE 59: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Canada 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Canada 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 65: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Canada 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
JAPAN
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 68: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Japan 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Japan 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 74: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Japan 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
CHINA
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 77: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: China Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: China 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: China Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: China 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 83: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: China Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: China 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
EUROPE
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 86: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Europe 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Europe 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Europe 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 95: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Europe 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
FRANCE
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 98: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: France Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: France 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 101: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: France Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: France 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 104: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: France Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: France 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
GERMANY
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 107: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Germany 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 110: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Germany 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 113: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Germany 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
ITALY
TABLE 116: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Italy 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 119: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Italy 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 122: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Italy 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
UNITED KINGDOM
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 125: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: UK Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: UK 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 128: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: UK Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: UK 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 131: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: UK Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: UK 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
SPAIN
TABLE 134: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Spain 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 137: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Spain 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 140: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Spain 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
RUSSIA
TABLE 143: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Russia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 146: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Russia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 149: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Russia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Rest of Europe 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Europe 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Europe 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Asia-Pacific 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Asia-Pacific 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 168: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Asia-Pacific 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Asia-Pacific 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
AUSTRALIA
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 173: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Australia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 176: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Australia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 179: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Australia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
INDIA
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 182: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: India Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: India 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 185: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: India Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: India 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 188: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: India Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: India 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 191: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: South Korea 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 194: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: South Korea 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 197: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: South Korea 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Rest of Asia-Pacific 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Rest of Asia-Pacific 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
LATIN AMERICA
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 209: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Latin America 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 212: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Latin America 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 215: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 216: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 217: Latin America 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 218: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 219: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 220: Latin America 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 221: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 222: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 223: Argentina 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 224: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 225: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 226: Argentina 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 227: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 228: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 229: Argentina 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
BRAZIL
TABLE 230: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 231: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 232: Brazil 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 233: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 234: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 235: Brazil 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 236: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 237: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 238: Brazil 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
MEXICO
TABLE 239: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 240: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 241: Mexico 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 242: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 243: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 244: Mexico 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 245: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 246: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 247: Mexico 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 249: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 250: Rest of Latin America 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 252: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 253: Rest of Latin America 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 255: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 256: Rest of Latin America 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
MIDDLE EAST
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 257: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 258: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 259: Middle East 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 260: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 261: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 262: Middle East 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 263: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 264: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 265: Middle East 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 266: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 267: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 268: Middle East 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
IRAN
TABLE 269: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 270: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 271: Iran 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 272: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 273: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 274: Iran 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 275: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 276: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 277: Iran 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
ISRAEL
TABLE 278: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 279: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 280: Israel 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 281: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 282: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 283: Israel 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 284: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 285: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 286: Israel 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 288: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 289: Saudi Arabia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 291: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 292: Saudi Arabia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 294: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 295: Saudi Arabia 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 296: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 297: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 298: UAE 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 299: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 300: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 301: UAE 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 302: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 303: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 304: UAE 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 306: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 307: Rest of Middle East 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 309: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 310: Rest of Middle East 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 312: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 313: Rest of Middle East 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
AFRICA
Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 314: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 315: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 316: Africa 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2014, 2024 & 2030
TABLE 317: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 318: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 319: Africa 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 320: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 321: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 322: Africa 16-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings